FDA Disease Awareness Ad Policy Is Unfair To Small Firms, BIO Says
Executive Summary
Restrictions on disease awareness advertisements proposed by FDA will hurt small biotech firms, the Biotechnology Industry Organization said
You may also be interested in...
Disease Awareness Ads Increase, Along With Firms’ Need For Clarity From FDA
Industry would like greater clarification from FDA on appropriate disease awareness advertising when the agency finalizes its draft guidance
Disease Awareness Ads Increase, Along With Firms’ Need For Clarity From FDA
Industry would like greater clarification from FDA on appropriate disease awareness advertising when the agency finalizes its draft guidance
Ads Linking “Help-Seeking” and Full Product Spots Helps Consumers – Pfizer
Similarities between branded ads and disease awareness ads may benefit consumers and should not be prohibited by FDA, Pfizer says